Seres Health
NASDAQ: MCRBCambridge, US · Founded 2010 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
JA
John AuninsExecutive
ED
Eric D. ShaffExecutive
DC
David CookExecutive
RJ
Roger J. PomerantzExecutive
RP
Roger PomerantzNamed on SEC filing
Board
DB

NA

GB
Greg BeharBoard director
PB
Peter Barton HuttBoard director
RK
Richard KenderBoard director
WC
Werner CautreelsBoard director
LK
Lorence KimBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$123.6M disclosed across 3 rounds · 2014
▶$65MraisedJan 2015 · 1 investors · PharmaceuticalsRule 506(b)
▶$65MraisedJan 2015 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Peter Barton HuttDirector
- Richard KenderDirector
- David BerryDirector
- Werner CautreelsDirector
- Noubar AfeyanDirector
- John AuninsExecutive Officer
- Eric D. ShaffExecutive Officer
- David CookExecutive Officer
- Lorence KimDirector
- Greg BeharDirector
- Roger J. PomerantzExecutive Officer, Director
- Offering amount
- $65M
- Amount sold
- $65M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$48MraisedDec 2014 · 20 investors · PharmaceuticalsRule 506(b)
▶$48MraisedDec 2014 · 20 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David BerryDirector
- Richard KenderDirector
- Werner CautreelsDirector
- Roger J. PomerantzExecutive Officer, Director
- John AuninsExecutive Officer
- Eric D. ShaffExecutive Officer
- Lorence KimDirector
- Noubar AfeyanDirector
- Peter Barton HuttDirector
- David CookExecutive Officer
- Offering amount
- $48M
- Amount sold
- $48M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$10.6MraisedJun 2014 · 10 investors · PharmaceuticalsRule 506(b)
▶$10.6MraisedJun 2014 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Werner CautreelsDirector
- David BerryDirector
- Noubar AfeyanDirector
- Roger PomerantzExecutive Officer, Director
- Peter Barton HuttDirector
- Offering amount
- $10.6M
- Amount sold
- $10.6M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Seres Health's investors?
- Seres Health's investors include Flagship Pioneering.
- How much funding has Seres Health raised?
- Seres Health has disclosed $123.6M raised across 3 rounds.
- Where is Seres Health headquartered?
- Seres Health is headquartered in Cambridge, US.
